Standard Travel Grants
All delegates submitting an abstract may apply for travel grants during the abstract submission process. Please note abstract submission is now closed.
Requirements: 40 years of age or less, ISPAD member (all dues paid), first author of an abstract. For applicants coming from: North America: 350 USD I South America: 700 USD I Europe: 1400 USD I Oceana: 1400 USD I Asia: 2000 USD
Please note that the travel grants may not cover all travel costs.
Travel grant awardees still need to pay registration fees and need to arrange their travel and accommodation.
Please see the table below for important dates.
|Abstract Submission starts||mid-Jan 14 - NOW CLOSED|
|Abstract Submission ends||09. Apr 14 - NOW CLOSED|
|Notifications to be sent||mid-June 14|
Developing World Initiative Travel Grants
Special travel grants will be awarded to delegates coming from non-high income countries (see the World Bank list at http://data.worldbank.org/about/country-classifications/country-and-lend... for reference.
The special travel grants are intended for people with financial difficulties, which otherwise would have prevented them from attending the meeting and include economy travel, housing and free registration.
The recipient of this grant is not expected to bring their spouse or other significant person to the meeting, as this would imply that the applicant is not in the economic position that this grant is reserved for.
Applications must be sent to the Secretary-General, Carine de Beaufort (firstname.lastname@example.org) with a CV, stating your current position and work for children with diabetes. There will be an application fee of 50 USD, which will be returned upon arrival in Toronto. The deadline for these travel grants is March 1, 2014 to allow sufficient time for travel planning and visa applications. Only participants who have submitted an abstract (including abstracts in the category â€œDiabetes project in developing countryâ€) for the meeting will be considered for these grants.
Please note these deadlines have now passed.